Skip to main content
L&C BIO Co., Ltd logo

L&C BIO Co., Ltd — Investor Relations & Filings

Ticker · 290650 ISIN · KR7290650001 KO Manufacturing
Open in API
Filings indexed 378 across all filing types
Latest filing 2021-03-31 Major Shareholding Noti…
Country KR South Korea
Listing KO 290650

About L&C BIO Co., Ltd

http://www.lncbio.co.kr/?locale=en_US

L&C BIO Co., Ltd. is a biotechnology company specializing in regenerative medicine. The company develops, manufactures, and commercializes human tissue-based medical devices and allograft treatment materials. Its core operations include the processing, storage, and distribution of human tissues, with a focus on skin, musculoskeletal, and soft tissues, utilizing patented processing technologies. The company's product portfolio also extends to other medical devices and cosmetics. L&C BIO supports its activities through dedicated research and development centers and manufacturing facilities, including a human tissue plant and a pharmaceutical plant, to advance its pipeline and serve global markets.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and purpose of holding (management influence) for L&C Bio. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2021-03-31 Korean
[기재정정]사업보고서 (2020.12)
Annual Report Classification · 95% confidence The document is a 'Correction Report' (정정신고) for an Annual Report (사업보고서) filed by L&C BIO. It details specific corrections made to the previously submitted Annual Report (originally filed on March 22, 2021) regarding board member status and stock option information following the 10th Annual General Meeting. Since this is a formal amendment to an existing Annual Report, it falls under the category of an Annual Report (10-K) filing, as it constitutes part of the official yearly reporting cycle and contains substantive financial and corporate governance data. FY 2020
2021-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed, financial statement approvals, dividend declarations, and board appointment outcomes from the meeting held on 2021-03-30. This fits the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2021-03-30 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) submitted to the Korea Exchange (KRX). It provides the audit opinion, key financial data (assets, liabilities, equity, profit/loss), and details regarding the external auditor (Hanul Accounting Corp). While it contains financial data, it is a summary disclosure of the audit results rather than the full Annual Report (10-K) or a standalone audit report document. In the context of Korean regulatory filings (DART/KIND), this is classified as an Audit Report/Information filing. FY 2020
2021-03-22 Korean
사업보고서 (2020.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Consolidated Audit Report' (연결감사보고서) for L&C Bio, covering the fiscal year ending December 31, 2020. It includes the independent auditor's report, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes. Since it contains full financial statements and audit results for a specific fiscal period, it is classified as an Annual Report (10-K). FY 2020
2021-03-22 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed under the Capital Markets Act in South Korea. It details the acquisition of shares by a major shareholder (Lee Whan-chul) and special related parties (family members and executives). This type of filing is specifically designed to notify the market when a person or entity crosses a significant ownership threshold (typically 5% or more) or changes their holdings significantly. In the provided taxonomy, this corresponds to a 'Major Shareholding Notification'.
2021-03-19 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.